R. A. Abrams

464 total citations
11 papers, 358 citations indexed

About

R. A. Abrams is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, R. A. Abrams has authored 11 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Epidemiology. Recurrent topics in R. A. Abrams's work include Pancreatic and Hepatic Oncology Research (7 papers), Neuroendocrine Tumor Research Advances (3 papers) and Cancer Genomics and Diagnostics (3 papers). R. A. Abrams is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Neuroendocrine Tumor Research Advances (3 papers) and Cancer Genomics and Diagnostics (3 papers). R. A. Abrams collaborates with scholars based in United States and United Kingdom. R. A. Abrams's co-authors include William H. Sherman, Jeanne M. Meis‐Kindblom, Kevin Murray, B. Fisher, Charles Scott, Christopher J. Schultz, Joshua Fields, Judy L. Cameron, Charles J. Yeo and Elliot K. Fishman and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

R. A. Abrams

11 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. A. Abrams United States	7	208	179	162	145	83	11	358
Timothy W. Bolek United States	5	127 0.6×	139 0.8×	114 0.7×	157 1.1×	72 0.9×	6	384
G. Trotter Australia	5	184 0.9×	224 1.3×	159 1.0×	201 1.4×	97 1.2×	5	444
Kenneth D. Herbst United States	8	80 0.4×	148 0.8×	87 0.5×	45 0.3×	81 1.0×	14	358
Vittorio Ruggero Zilioli Italy	10	61 0.3×	156 0.9×	112 0.7×	125 0.9×	23 0.3×	33	329
Emanuela Merla Italy	11	83 0.4×	297 1.7×	108 0.7×	143 1.0×	44 0.5×	17	390
H Schefer Switzerland	6	38 0.2×	163 0.9×	88 0.5×	141 1.0×	57 0.7×	14	336
S. Wiedenmann Germany	8	94 0.5×	278 1.6×	94 0.6×	182 1.3×	66 0.8×	8	350
Mi-Ryeong Ryu South Korea	9	77 0.4×	104 0.6×	77 0.5×	59 0.4×	68 0.8×	11	444
F. Soncini Italy	7	115 0.6×	280 1.6×	73 0.5×	163 1.1×	107 1.3×	9	342
C Ghandour France	11	64 0.3×	284 1.6×	101 0.6×	189 1.3×	82 1.0×	17	390

Countries citing papers authored by R. A. Abrams

Since Specialization

Citations

This map shows the geographic impact of R. A. Abrams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. A. Abrams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. A. Abrams more than expected).

Fields of papers citing papers by R. A. Abrams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. A. Abrams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. A. Abrams. The network helps show where R. A. Abrams may publish in the future.

Co-authorship network of co-authors of R. A. Abrams

This figure shows the co-authorship network connecting the top 25 collaborators of R. A. Abrams. A scholar is included among the top collaborators of R. A. Abrams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. A. Abrams. R. A. Abrams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Hurt, Chris, John Bridgewater, Stephen Falk, et al.. (2016). O-003 Long-term outcome from the SCALOP trial: a multi-centre randomized phase II trial of gemcitabine or capecitabine-based chemoradiation (CRT) for locally advanced pancreatic cancer (LAPC). Annals of Oncology. 27. ii118–ii118. 6 indexed citations

Moughan, Jennifer, Christopher H. Crane, John P. Hoffman, et al.. (2011). Association of RecQ1 A159C polymorphism with overall survival of patients with resected pancreatic cancer: A replication study in RTOG 9704.. Journal of Clinical Oncology. 29(4_suppl). 156–156. 1 indexed citations

Farrell, James J., Marius van Rijnsoever, R. A. Abrams, et al.. (2005). THYMIDYLATE SYNTHASE AND THYMIDINE PHOSPHORYLASE: PROTEIN EXPRESSION AND GENOTYPE IN PANCREATIC CANCER: RESULTS FROM THE RTOG 9704 PROSPECTIVE RANDOMIZED ADJUVANT TREATMENT TRIAL. Pancreas. 31(4). 439–440. 1 indexed citations

Movsas, Benjamin, Jennifer Moughan, Ritsuko Komaki, et al.. (2002). Radiotherapy (RT) patterns of care study (PCS) in lung carcinoma. International Journal of Radiation Oncology*Biology*Physics. 54(2). 101–102. 4 indexed citations

Rich, Tyvin A., Jonathan Harris, R. A. Abrams, et al.. (2001). A phase II study of external irradiation and weekly paclitaxel for non-metastatic, unresectable pancreatic cancer: a preliminary report of RTOG Protocol 98-12. International Journal of Radiation Oncology*Biology*Physics. 51(3). 29–30. 11 indexed citations

Bluemke, David A., R. A. Abrams, Charles J. Yeo, Judy L. Cameron, & Elliot K. Fishman. (1997). Recurrent pancreatic adenocarcinoma: spiral CT evaluation following the Whipple procedure.. Radiographics. 17(2). 303–313. 42 indexed citations

Sohn, T. A., et al.. (1997). Pancreaticoduodenectomy and palliation in pancreatic carcinoma. Gastroenterology. 112(3). 1046–1048. 8 indexed citations

Schultz, Christopher J., Charles Scott, William H. Sherman, et al.. (1996). Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06.. Journal of Clinical Oncology. 14(2). 556–564. 208 indexed citations

Yeo, Charles J., Ralph H. Hruban, S E Kern, et al.. (1994). Adenocarcinoma of the pancreas: Factors influencing outcome after pancreaticoduodenectomy - The Johns Hopkins experience. 46(6). 504–510. 9 indexed citations

10.

Pilepich, M.V., Richard Caplan, Majnu John, et al.. (1993). Phase III trial of hormonal cytoreduction in conjunction with definitive radiotherapy in locally advanced prostate carcinoma: the emerging role of psa in the assessment of outcome. International Journal of Radiation Oncology*Biology*Physics. 27. 246–246. 8 indexed citations

11.

Ihde, Daniel C., A B Deisseroth, Allen S. Lichter, et al.. (1986). Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer.. Journal of Clinical Oncology. 4(10). 1443–1454. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact